SeaStar Medical
ICU | NASDAQ
$3.58
+$0.04 (+1.13%)
At close: Sep 21, 2026, 4:00 PM ET
$3.56
-$0.02 (-0.45%)
Pre-market:
Sep 22, 2026, 7:28 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.23M | 135K | n/a | n/a | n/a | n/a |
Cost of Revenue | 53K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 1.18M | 135K | n/a | n/a | n/a | n/a |
Operating Income | -12.18M | -17.84M | -14.21M | -11.61M | -4.45M | -6.45M |
Interest Income | 325K | 101K | n/a | 630 | n/a | n/a |
Pretax Income | -12.15M | -24.83M | -26.23M | -12.19M | -4.6M | -3.27M |
Net Income | -12.15M | -24.83M | -26.23M | -12.19M | -4.6M | -3.28M |
Selling & General & Admin | 5.84M | 8.87M | 8.04M | 6.92M | 1.68M | 2.43M |
Research & Development | 7.52M | 9.11M | 5.97M | 2.5M | 2.77M | 4.03M |
Other Expenses | n/a | n/a | 200K | 2.19M | n/a | n/a |
Operating Expenses | 13.36M | 17.98M | 14.21M | 11.61M | 4.45M | 6.45M |
Interest Expense | 329K | 244K | 1.08M | 630K | 212K | 3.31M |
Selling & Marketing Expenses | n/a | n/a | 32K | n/a | n/a | 65K |
Cost & Expenses | 13.41M | 17.98M | 14.21M | 11.61M | 4.45M | 6.45M |
Income Tax Expense | 3K | 3K | n/a | 1K | -1K | 9K |
Shares Outstanding (Basic) | 20.73M | 374.4K | 86.68K | 52.13K | 52.16K | 52.16K |
Shares Outstanding (Diluted) | 20.73M | 374.4K | 86.68K | 52.13K | 52.16K | 52.16K |
EPS (Basic) | -5.86 | -66.30 | -302.62 | -233.80 | -88.10 | -0.10 |
EPS (Diluted) | -5.86 | -66.30 | -302.62 | -233.80 | -88.10 | -0.10 |
EBITDA | -12.16M | -24.58M | -11.14M | -11.56M | -4.39M | n/a |
EBIT | -12.18M | -24.58M | -25.15M | -11.56M | -4.39M | -6.45M |
Depreciation & Amortization | 18K | n/a | 14.01M | n/a | n/a | 6.45M |
Add to Watchlist
Select watchlists to add or remove ICU